PRELUDE CAPITAL MANAGEMENT, LLC - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 67 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q3 2017$11,000
+83.3%
11,300
+6.6%
0.00%0.0%
Q2 2017$6,000
+500.0%
10,600
+1414.3%
0.00%
Q2 2016$1,0007000.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,998,941$5,839,0002.81%
Knoll Capital Management, LLC 3,400,816$4,965,0001.95%
Third Security, LLC 12,300,768$17,960,0000.82%
MSD Partners, L.P. 3,583,500$5,232,0000.12%
Genesis Wealth Advisors, LLC 35,000$78,750,0000.06%
THOMPSON DAVIS & CO., INC. 20,000$29,0000.03%
TFS CAPITAL LLC 157,800$230,0000.02%
HAMILTON LANE ADVISORS LLC 23,855$35,0000.01%
WEDBUSH SECURITIES INC 12,000$18,0000.00%
REGIONS FINANCIAL CORP 100,000$146,0000.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders